Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 12.26
+0.24 (2.00%)
At close: Jul 23, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 555.66 million as of July 24, 2026. Its market cap has decreased by -31.62% in one year.
Market Cap
555.66M
Enterprise Value
132.74M
Revenue
67.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.26
ChartMarket Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 555.66M, a decrease of -63.38%. That is a compound annual growth rate of -38.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 555.66M | -38.01% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.69B |
| Cereno Scientific AB | 1.54B |
| Nanexa AB | 678.17M |
| Dicot Pharma AB | 622.98M |
| EQL Pharma AB | 608.31M |
| Orexo AB | 532.21M |
| Enzymatica AB | 456.34M |
| Moberg Pharma AB | 438.52M |